- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
ATL loses appeal on SRI lawsuit
ATL Ultrasound announced last month that the U.S. Court of Appeals affirmed a lower court decision in the patent litigation filed against the Bothell, WA-based vendor by SRI International. ATL does not plan to appeal further, which brings the case to a
ATL Ultrasound announced last month that the U.S. Court of Appeals affirmed a lower court decision in the patent litigation filed against the Bothell, WA-based vendor by SRI International. ATL does not plan to appeal further, which brings the case to a close. The company has already set aside $37.1 million in prior financial periods to cover the full cost of the judgment, which was awarded in 1996 (SCAN 6/5/96). SRI filed the suit in 1991, charging ATL with violating a patent SRI received in 1977 for tracking filter circuits used in ATL's Ultramark 4, Ultramark 5, and ADR 4000 ultrasound scanners, all of which have been discontinued. The relevant patent expired in 1994, according to ATL.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
